'Ranbaxy systematically violated good manufacturing practices'
PRESS TRUST OF INDIA
Washington, May 14: Ranbaxy Laboratories "systemically violated" good manufacturing practices, says the whisteblower whose alert led to a US probe, a day after India's top drugmaker agreed to pay a hefty USD 500 million to settle charges over its adulterated drugs.
The generic drugs at issue were manufactured at Ranbaxy's facilities in Paonta Sahib and Dewas in India and included acne drug Sotret, epilepsy and nerve pain drug gabapentin and antibiotic ciprofloxacin.
"Eight years ago, as the Director of Project and Information Management at Ranbaxy, I discovered that the company falsified drug data and systemically violated current good manufacturing practices and good laboratory practices," Dinesh Thakur, a former Ranbaxy executive who is settled in US now, said in a statement.
When Ranbaxy failed to correct problems, he alerted healthcare authorities.
The Generic drugmaker pleaded guilty yesterday to felony charges related to drug safety and will pay USD 500 million in civil and criminal fines under the settlement agreement with the US Department of Justice.
Thakur, of Belle Mead, New Jersey, will receive USD 48.6 million from the USD 500 million that Ranbaxy agreed to pay to settle allegations that the company sold adulterated drugs manufactured at its Paonta Sahib and Dewas plants.
"This case highlights the need for effective regulation that applies to drugs sold in the United States, regardless where they are manufactured," Thakur said. "I am relieved that the government's investigation has concluded."
The settlement is its largest-ever with a generic drugmaker over drug safety, according to the US government. It includes $150 million in payments for a criminal fine and forfeiture and $350 million in payments for civil claims.
Ranbaxy USA pleaded guilty to three felony counts under the Food, Drug and Cosmetic Act -- which prohibits adulterated drugs -- and four felony counts of knowingly making material false statements to the US Food and Drug Administration.
Lastupdate on : Tue, 14 May 2013 21:30:00 Makkah time
Lastupdate on : Tue, 14 May 2013 18:30:00 GMT
Lastupdate on : Wed, 15 May 2013 00:00:00 IST
- MORE FROM WORLD
Seeks Response From Government, Police
Srinagar, May 14: Observing that use of pellet guns by government forces was a serious threat to life, the State Human Rights Commission has issued notices to J&K Government and Director General of More
- JK awaits Home Ministry's nod for repartition of 11 Pak prisoners
- Mulberry films to adapt ‘The Collaborator’
- After Omar Abdullah, Mehbooba asks people to take cue from Pak voters
- Kunanposhpora: High Court says ‘not inclined to entertain PIL at this stage’
- Governor reviews Yatra arrangements at Base Camps
- Srinagar City
Srinagar, May 14: Spotting over a hundred stray dogs on prowl around could be scary and equally deadly, but this is a routine for the people living in this summer Capital while the politicians from the More
Inspects Developmental Works
Doda, May 14: Union Minister for Health and Family Welfare Ghulam Nabi Azad, who is on a visit to the earthquake-affected Doda district, Tuesday visited quake hit areas of Bhaderwah, Ghat and Doda town More
- South Asia
NISAR AHMED THOKAR
Islamabad, May 14: Chairman of the United Jehad Council (UJC) Syed Salahuddin has felicitated the PML-N Chief Nawaz Sharif on his landmark victory in the recent polls in Pakistan.“We express our sincere More
London, May 14: Lord Nazir Ahmed, the British parliamentarian of Kashmiri origin, has ended his nearly four decades old affiliation with the Labour Party with “a heavy heart” following a row over his alleged More
- Gk Features
A Kashmiri Muslim family has been taking care of a cremation ground for Pandits for over a century in the interiors of Dal Lake
For over a century a Kashmiri Muslim family in Jala Mohalla in the interiors of Dal Lake on the Rainawari side has been taking care of a cremation ground for Kashmiri Pandits even after their migration More